BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17208431)

  • 21. Progression elevated gene-3 (PEG-3) induces pleiotropic effects on tumor progression: modulation of genomic stability and invasion.
    Emdad L; Sarkar D; Su ZZ; Boukerche H; Bar-Eli M; Fisher PB
    J Cell Physiol; 2005 Jan; 202(1):135-46. PubMed ID: 15389539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the cell-cycle-regulated NIMA protein kinase during G2 and mitosis: evidence for two pathways of mitotic regulation.
    Osmani AH; McGuire SL; O'Donnell KL; Pu RT; Osmani SA
    Cold Spring Harb Symp Quant Biol; 1991; 56():549-55. PubMed ID: 1819506
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting cell cycle kinases for cancer therapy.
    de Cárcer G; Pérez de Castro I; Malumbres M
    Curr Med Chem; 2007; 14(9):969-85. PubMed ID: 17439397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.
    Bullrich F; MacLachlan TK; Sang N; Druck T; Veronese ML; Allen SL; Chiorazzi N; Koff A; Heubner K; Croce CM
    Cancer Res; 1995 Mar; 55(6):1199-205. PubMed ID: 7882308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BUB1 and BUBR1: multifaceted kinases of the cell cycle.
    Bolanos-Garcia VM; Blundell TL
    Trends Biochem Sci; 2011 Mar; 36(3):141-50. PubMed ID: 20888775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spindle checkpoint proteins and chromosome-microtubule attachment in budding yeast.
    Gillett ES; Espelin CW; Sorger PK
    J Cell Biol; 2004 Feb; 164(4):535-46. PubMed ID: 14769859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication.
    Stucke VM; Silljé HH; Arnaud L; Nigg EA
    EMBO J; 2002 Apr; 21(7):1723-32. PubMed ID: 11927556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polo-like kinases and Chk2 at the interface of DNA damage checkpoint pathways and mitotic regulation.
    Tsvetkov L
    IUBMB Life; 2004 Aug; 56(8):449-56. PubMed ID: 15545224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aurora kinases: structure, functions and their association with cancer.
    Kollareddy M; Dzubak P; Zheleva D; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):27-33. PubMed ID: 18795071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roles of polo homologous kinases in cell division--diversity and conservation].
    Ohkura H
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1863-8. PubMed ID: 8890648
    [No Abstract]   [Full Text] [Related]  

  • 33. A dual role for Bub1 in the spindle checkpoint and chromosome congression.
    Meraldi P; Sorger PK
    EMBO J; 2005 Apr; 24(8):1621-33. PubMed ID: 15933723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrosome cohesion is regulated by a balance of kinase and phosphatase activities.
    Meraldi P; Nigg EA
    J Cell Sci; 2001 Oct; 114(Pt 20):3749-57. PubMed ID: 11707526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathology of the cell cycle in human cancer cells.
    Bártek J; Stasková Z; Draetta G; Lukás J
    Stem Cells; 1993 May; 11 Suppl 1():51-8. PubMed ID: 8318919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid.
    Fagin JA
    Mol Endocrinol; 2002 May; 16(5):903-11. PubMed ID: 11981026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polo-like kinases and the microtubule organization center: targets for cancer therapies.
    Dai W; Cogswell JP
    Prog Cell Cycle Res; 2003; 5():327-34. PubMed ID: 14593727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
    Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
    Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of NEK family in cell cycle regulation.
    Li YY; Guo L; Han ZM
    Yi Chuan; 2021 Jul; 43(7):642-653. PubMed ID: 34284980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIMA-related kinases defective in murine models of polycystic kidney diseases localize to primary cilia and centrosomes.
    Mahjoub MR; Trapp ML; Quarmby LM
    J Am Soc Nephrol; 2005 Dec; 16(12):3485-9. PubMed ID: 16267153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.